The global AI in endoscopy market is experiencing rapid expansion, reflecting the broader transformation of healthcare through advanced digital technologies. Valued at USD 1.85 billion in 2025, the market is projected to grow significantly, reaching USD 19.7 billion by 2036, with a strong compound annual growth rate of 22.4% during the forecast period. This growth trajectory is driven by the increasing integration of artificial intelligence into clinical workflows, particularly in diagnostic and procedural settings where accuracy, efficiency, and consistency are critical. By 2026, the market is expected to reach USD 2.31 billion, marking an early phase of accelerated adoption across both developed and emerging healthcare systems.
Market Definition and Core Technologies
Artificial intelligence in endoscopy encompasses a wide range of technologies, including machine learning, deep learning, computer vision, natural language processing, and predictive analytics. These technologies are applied across software platforms, integrated endoscopic systems, and associated services, all designed to enhance the capabilities of clinicians during procedures and in post-procedure analysis. In practical clinical use, AI solutions are primarily categorized into two major functional types: computer-aided detection and computer-aided diagnosis or characterization. Detection systems operate in real time, identifying and highlighting potential abnormalities within live video streams, thereby improving lesion detection rates and reducing the likelihood of missed findings. Diagnostic systems, on the other hand, focus on characterizing identified lesions, offering insights into their morphology and malignancy risk, and supporting immediate clinical decision-making.
Workflow Optimization and Advanced Capabilities
Beyond these core functionalities, the scope of AI in endoscopy is expanding to include workflow optimization tools. These solutions address key operational challenges within endoscopy units by automating tasks such as bowel preparation assessment, monitoring withdrawal time, ensuring adequate mucosal coverage, and generating standardized reports through natural language processing. The introduction of such capabilities not only improves efficiency but also enhances adherence to clinical quality benchmarks. Additionally, AI-driven disease activity scoring systems are increasingly being used in chronic conditions, enabling more consistent and objective evaluation of disease progression.
Dominance of Gastrointestinal Applications
The market is witnessing strong momentum in gastrointestinal applications, which are expected to dominate in 2026. This dominance is largely attributed to the widespread use of colonoscopy in colorectal cancer screening programs. Colorectal cancer remains one of the most common cancers globally, with millions of new cases reported annually. Traditional colonoscopy procedures are associated with notable miss rates, particularly for small or flat lesions. AI-assisted systems have demonstrated significant improvements in detection rates, with clinical studies indicating reductions in miss rates of up to 40–50%. These outcomes have reinforced the clinical value of AI integration, contributing to its growing acceptance as a standard component of high-quality endoscopic care.
Clinical Evidence and Guideline Support
The strengthening clinical evidence base has played a crucial role in driving market adoption. Over recent years, research has evolved from early feasibility studies to large-scale randomized controlled trials demonstrating measurable improvements in key quality metrics such as adenoma detection rate. These improvements are clinically meaningful, as even small increases in detection rates are associated with reduced long-term cancer risk. As a result, professional medical societies have begun to recognize and endorse the use of AI-assisted systems, further accelerating their adoption across healthcare institutions.
Expansion into Adjacent Clinical Areas
While gastrointestinal endoscopy remains the primary focus, AI applications are expanding into adjacent clinical areas. In upper gastrointestinal procedures, AI is being used to improve detection of conditions such as early-stage cancers and precancerous changes, which are often subtle and difficult to identify. Similarly, in inflammatory bowel disease, AI tools are helping standardize disease activity assessments, reducing variability between clinicians. Capsule endoscopy is another growing area, where AI significantly reduces the time required for video analysis while improving diagnostic yield. Beyond gastrointestinal applications, the technology is also being explored in respiratory and urological endoscopy, where it shows promise in enhancing lesion detection and procedural accuracy.
Technology Trends and Innovation Landscape
From a technological perspective, machine learning and deep learning are expected to account for the largest share of the market. These approaches are particularly well suited to image and video analysis, enabling real-time processing of endoscopic data with high accuracy and low latency. Deep learning models trained on large datasets have demonstrated performance levels comparable to experienced clinicians, making them a cornerstone of AI-driven endoscopy solutions. At the same time, natural language processing is emerging as the fastest-growing technology segment, driven by the need to automate documentation and reporting processes that are traditionally time-consuming and prone to inconsistencies.
Component Insights and Deployment Models
In terms of components, software and AI algorithms represent the largest segment of the market. The value of AI in endoscopy is primarily derived from the performance of these algorithms, which determine detection accuracy, false-positive rates, and overall system reliability. These software solutions can be deployed through various models, including integration with existing systems, embedded configurations, and cloud-based platforms. Cloud deployment, in particular, is gaining traction due to its scalability, lower upfront costs, and ability to support continuous updates. Meanwhile, the services segment is expected to grow at the fastest rate, reflecting the increasing demand for implementation support, system integration, training, and ongoing maintenance.
End User Insights and Adoption Patterns
Hospitals and endoscopy centers are the primary end users of AI in endoscopy, accounting for the largest share of the market. These facilities typically handle high volumes of procedures and are better equipped with the infrastructure and resources required to adopt advanced technologies. They also benefit from improved workflow efficiency and enhanced quality monitoring enabled by AI systems. However, ambulatory surgical centers are expected to witness the fastest growth, driven by the ongoing shift of routine procedures to outpatient settings. In these environments, AI is increasingly being used as a tool for quality differentiation and performance benchmarking.
Regional Market Dynamics
Geographically, North America is expected to maintain its leading position in the market, supported by early regulatory approvals, strong clinical research activity, and high healthcare spending. Europe follows as the second-largest market, benefiting from early guideline adoption and robust clinical validation. Asia Pacific is projected to experience the fastest growth, driven by expanding healthcare infrastructure, large patient populations, and increasing government support for AI integration. Countries within this region are also contributing significantly to research and development in AI-assisted endoscopy, further accelerating adoption.
Future Outlook and Market Evolution
Overall, the global AI in endoscopy market is undergoing a transformative phase characterized by rapid technological advancement, growing clinical validation, and expanding application areas. The integration of AI into endoscopic practice is not only improving diagnostic accuracy but also enhancing procedural efficiency and patient outcomes. As healthcare systems continue to prioritize quality and value-based care, AI in endoscopy is expected to become an essential component of modern clinical practice, driving sustained growth over the coming decade.
Download Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=6621
Key Questions Answered
What is the projected market size of the global AI in endoscopy market by 2036?
At what CAGR is the AI in endoscopy market expected to grow during 2026–2036?
What are the key factors driving the growth of AI in endoscopy globally?
How does AI improve adenoma detection rates in colonoscopy procedures?
What are the primary differences between computer-aided detection (CADe) and computer-aided diagnosis (CADx) systems?
Why is gastrointestinal endoscopy expected to dominate the market in 2026?
What role does clinical evidence and guideline endorsement play in accelerating AI adoption in endoscopy?
Which AI technologies are most widely used in endoscopy applications?
Why is natural language processing (NLP) considered the fastest-growing segment in this market?
What are the key workflow optimization benefits offered by AI in endoscopy?
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research